The MEDlife addresses health challenges by researching disease mechanisms, developing sustainable therapeutic solutions, and translating innovations through patents and start-ups. It integrates multidisciplinary teams from Lisbon, Coimbra, and Porto to advance drug discovery and therapeutic applications in oncology, infectious, neurodegenerative, and metabolic diseases. The cluster’s strong focus on collaboration, intellectual property, and commercialisation supports the re-industrialization of the European health sector and fosters innovation through start-ups and advanced training.